Cells in the G0 phase have stepped out of the active division cycle and entered a state often called quiescence. They are not dividing, not copying their DNA, and not preparing to split in two. But calling G0 a resting phase undersells what is actually going on inside these cells. They remain metabolically active, carry out specialized functions, tighten their chromatin packaging, repair DNA damage, and in many cases stand ready to jump back into the cycle if the right signal arrives. Most cells in your body right now are in G0, including neurons, muscle fibers, and the vast majority of liver cells, so understanding this phase means understanding the default state of most human tissue.
How Cells Enter G0
A cell heading toward G0 has to hit the brakes on the molecular machinery that drives division. The key brake pads are proteins called cyclin-dependent kinase inhibitors, particularly two called p21 and p27. These proteins block the enzymes (cyclin-dependent kinases) that would otherwise push the cell forward through the division cycle. When p21 and p27 levels rise, the cell stalls in the gap before DNA replication and can slip sideways into G0 instead of continuing onward.1PubMed Central. P21 and p27: roles in carcinogenesis and drug resistance
How important are these proteins? Studies in mice missing the gene for p21 showed that after partial removal of the liver, hepatocytes raced through the pre-replication phase far faster than normal. DNA synthesis kicked off earlier, key cell-cycle proteins appeared sooner, and the whole regeneration timeline compressed. Meanwhile, p27 was already present in the quiescent liver before any surgery, helping keep those resting cells from spontaneously re-entering the cycle.2Oncogene. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver The picture that emerges is that p27 helps hold the door to G0 shut, while p21 governs how quickly a cell can leave once it decides to.
The decision point itself sits early in the gap phase before DNA replication. A cell that has not yet passed a checkpoint called the restriction point can veer off into G0. Once it crosses that threshold, it is committed to dividing. This restriction point concept was first proposed in the 1970s, and it remains central to how biologists think about the G0 boundary.3Oxford Academic. Cell cycle arrest in plants: what distinguishes quiescence, dormancy and differentiated G1?
Gene Silencing by the DREAM Complex
Entering G0 is not just about slamming the brakes. The cell also needs to shut down a whole network of genes whose products would otherwise keep nudging it toward division. A large protein assembly called the DREAM complex handles much of this job. During G0, DREAM binds to the promoter regions of hundreds of cell-cycle genes and keeps them silent. When a cell receives growth signals and begins to re-enter the cycle, DREAM releases those genes and allows a coordinated wave of expression, with some genes peaking during DNA synthesis and others peaking just before the cell physically divides.4PubMed Central. The DREAM complex: master coordinator of cell cycle-dependent gene expression
Think of DREAM as a master dimmer switch for the cell’s proliferation program. In G0, the lights are down. The genes are still there, intact and ready, but their transcription is actively suppressed. This prevents the kind of accidental or low-level gene activity that might push a cell back into the cycle prematurely. When DREAM function is disrupted, cells have trouble maintaining proper G0 arrest, which hints at why DREAM pathway defects show up in certain cancers.
Chromatin Gets Tighter
One of the most striking physical changes in a G0 cell is that its DNA packaging becomes noticeably more compact. Human fibroblasts pushed into quiescence show tighter chromatin compaction than their actively dividing counterparts, and mass spectrometry reveals that specific chemical marks on histone proteins shift during this transition. In particular, certain methylation marks on histone H4 increase in quiescent cells. When the enzyme responsible for adding one of these marks is knocked out, cells have trouble exiting the cycle and their chromatin fails to compact properly, suggesting that these histone modifications are not just passengers along for the ride but active drivers of the G0 state.5PubMed Central. H4K20 methylation regulates quiescence and chromatin compaction
At a larger scale, a protein complex called condensin creates loop structures in the DNA that span tens of thousands of base pairs and exist only in quiescent cells. These condensin-mediated loops pull chromatin into tighter domains and broadly silence transcription across the genome. When researchers depleted condensin in quiescent cells, the compact domains loosened and genes that should have been silent started turning back on.6PubMed Central. Condensin-Dependent Chromatin Compaction Represses Transcription Globally during Quiescence So chromatin compaction in G0 is not just a space-saving measure. It is a functional silencing strategy that reinforces the decision to stop dividing.
DNA Repair Still Happens
A common misconception is that cells in G0 are somehow frozen and protected from damage. They are not. Quiescent cells face ongoing threats from normal metabolic byproducts like reactive oxygen species, from background radiation, and even from the act of transcribing their own genes. Because most cells in the body spend most of their time in G0, the cumulative damage that accrues in this phase matters enormously for tissue health and aging.7PubMed Central. From rest to repair: Safeguarding genomic integrity in quiescent cells
The repair toolkit available in G0 is different from what a dividing cell uses. Actively cycling cells can fix double-strand DNA breaks using a sister chromosome as a template, a high-fidelity method that requires the cell to have recently copied its DNA. G0 cells do not have that option. Instead, they rely on a method called non-homologous end joining, which essentially glues broken DNA ends back together, along with a backup pathway called alternative end joining.8PubMed Central. DNA End Joining: G0-ing to the Core These pathways are less precise, which means quiescent cells accumulate small errors over time. For a neuron that will spend decades in G0, those errors add up, and this is one reason why genome instability in non-dividing tissues is a growing area of aging research.
Interestingly, while many DNA repair pathways are turned down in quiescent cells compared to dividing ones, emerging evidence suggests that some repair mechanisms are differentially regulated rather than simply weakened, as if the cell is prioritizing certain kinds of fixes over others.7PubMed Central. From rest to repair: Safeguarding genomic integrity in quiescent cells The cell is making triage decisions about which damage is worth fixing with limited resources.
Quiescence Has Depth
G0 is not a single uniform state. Cells can be shallowly quiescent, needing only a modest growth signal to re-enter the cycle, or deeply quiescent, requiring much stronger stimulation. Researchers have shown this by measuring how much growth factor is needed to flip a molecular switch (the Rb-E2F bistable switch) that commits a cell to leaving G0. Cells that have been quiescent longer, or that were pushed into quiescence more firmly, sit deeper and need a stronger push to come back.9Cell Reports. Rb-E2F Bistable Switch Controls Restinog Factor and Quiescence Depth in Mammalian Cells
This graded quality of quiescence turns out to be regulated by a surprising mechanism involving a cellular recycling system called the lysosome. As cells sit in G0 longer, lysosomal activity shifts in ways that deepen quiescence progressively. Shallow quiescent cells retain a higher tendency to revert to proliferation, while deep quiescent cells are harder to wake up but remain fully capable of doing so under the right conditions. This distinguishes deep quiescence from senescence, a related but fundamentally different state where cells have essentially lost the ability to divide permanently.10PubMed Central. Graded regulation of cellular quiescence depth between proliferation and senescence by a lysosomal dimmer switch
The practical importance of quiescence depth is hard to overstate. It explains, for instance, why some stem cells can be mobilized quickly after injury while others take days to respond. It also helps explain why some dormant cancer cells resist therapy for years and then suddenly reactivate.
Stem Cells and the Strategic Use of G0
Many of the body’s adult stem cells spend most of their existence in G0. Hematopoietic stem cells in the bone marrow, the cells responsible for producing every type of blood cell, sit in specialized microenvironments called niches that actively maintain their quiescence. These niches provide signals that keep the stem cells from dividing unnecessarily, preserving them for when they are actually needed. Coordinating terminal differentiation with permanent exit from the cell cycle is a fundamental challenge in organ development, and disruptions to this coordination can lead to developmental defects or cancer.11PubMed Central. Mechanisms controlling cell cycle exit upon terminal differentiation
Muscle stem cells, called satellite cells, provide one of the clearest examples of G0 in action. In healthy adult muscle, satellite cells sit quietly beneath the outer membrane of muscle fibers, doing essentially nothing visible. When the muscle is injured, signals from the damaged tissue wake them up. They re-enter the cell cycle, proliferate to generate new muscle cells, and then a subset returns to G0 to replenish the reserve pool for next time. This cycling between G0 and active proliferation is what allows muscle to regenerate after injury throughout life.
Recent single-cell studies have revealed that even within a supposedly uniform population of quiescent stem cells, there is surprising molecular diversity. Quiescent melanocyte stem cells, for instance, break down into multiple subpopulations with different surface markers, different predicted differentiation potential, and different quiescence depths.12PubMed Central. Molecular heterogeneity of quiescent melanocyte stem cells revealed by single-cell RNA-sequencing What looks like a single resting population under a microscope turns out to be a mosaic of subtly different cell states when you examine gene expression cell by cell.
How Cells Leave G0
The exit from G0 is not an all-at-once event. It unfolds in stages, beginning when growth factor signals reach the cell and activate a cascade that ultimately disables the Rb protein, a master brake on cell-cycle entry. Rb works by physically binding to and silencing transcription factors that would turn on genes needed for DNA replication. The first step in releasing that brake is mono-phosphorylation of Rb by a specific kinase complex. This initial modification, driven by cyclin D paired with CDK4 or CDK6, generates multiple distinct Rb isoforms in the early gap phase and begins loosening Rb’s grip on the transcription factors it suppresses.13PubMed Central. Cyclin D activates the Rb tumor suppressor by mono-phosphorylation
As the process continues, additional phosphorylation events fully inactivate Rb, the transcription factors it was holding hostage go to work, and the cell commits to DNA replication. The whole sequence takes hours to complete, and at multiple points the cell can still abort the process and return to G0 if the growth signals waver. Only after passing the restriction point does the cell become self-sustaining in its march toward division, independent of external growth signals.
G0 in Cancer and Treatment Resistance
The same quiescence machinery that protects normal stem cells also protects cancer cells from therapies designed to kill dividing cells. Quiescent cancer cells sit in G0, express low levels of the proliferation marker Ki67 and high levels of the CDK inhibitor p27, and thereby dodge most chemotherapies, which tend to target cells that are actively synthesizing DNA or preparing to divide. Some treatments can even increase the proportion of quiescent cells in a tumor by selectively killing the dividing ones.14PubMed Central. Quiescent Cancer Cells-A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
These dormant cancer cells are a major suspected driver of relapse. A patient can complete treatment, show no detectable disease, and then months or years later see the cancer return. The leading explanation is that quiescent cancer cells survived the initial therapy, sat in G0 waiting for favorable conditions, and then re-entered the cell cycle. Recent research has uncovered one surprising trigger for this reawakening: chemotherapy itself. In a mouse model, the drug doxorubicin induced immune cells called neutrophils to release web-like structures that inadvertently woke up dormant cancer cells in the lung, promoting metastatic relapse. Combining the chemotherapy with senolytic drugs (dasatinib and quercetin) inhibited this reactivation and suppressed metastasis.15PubMed. Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps
This finding is part of a broader push to develop strategies that target the G0 state specifically rather than only targeting dividing cells. Some approaches aim to force quiescent cancer cells back into the cycle where they become vulnerable to conventional chemotherapy. Others aim to lock them in G0 permanently or eliminate them while dormant. The challenge is that many of the same molecular features that define cancerous G0 cells also define normal quiescent stem cells, so any drug targeting quiescence risks harming healthy tissue.
The Boundary Between Quiescence and Senescence
Quiescence and senescence are both states of cell-cycle arrest, but they are fundamentally different in their reversibility. A quiescent cell can, in principle, return to the cell cycle. A senescent cell generally cannot. Senescent cells also develop a distinct secretory profile, pumping out inflammatory signals that affect their neighbors, whereas quiescent cells are relatively quiet in this regard.
Recent single-cell RNA sequencing work has complicated this neat distinction. After chemotherapy treatment, researchers paired time-lapse imaging of cell behavior with gene expression profiling and found that quiescence and senescence exist on a continuum rather than as two sharply separated states. Cells that initially appeared to be in shallow quiescence gradually acquired senescent features at the transcriptome level, and cells that took different paths through mitosis (normal division versus a failed division called mitotic slip) ended up in different senescent subtypes.16Nature Communications. Single-cell RNA sequencing reveals a quiescence-senescence continuum and distinct senotypes following chemotherapy The implication is that a cell does not make a single binary choice between quiescence and senescence. Instead, it drifts along a spectrum, and where it lands depends on how it arrived and what it experienced along the way.
This continuum matters for cancer therapy because senescent cells are not harmless bystanders. They accumulate after treatment, and their inflammatory secretions can reshape the tumor environment in ways that may ultimately help surviving cancer cells. Combining standard treatment with senolytic drugs that clear out senescent cells is an active area of clinical investigation, with the goal of removing these problematic cells before their secretions do additional damage.17International Journal of Oral Science. Persistent accumulation of therapy-induced senescent cells: an obstacle to long-term cancer treatment efficacy
G0 in Plants
The G0 concept is not unique to animal cells. Plant cells also exit the active cycle and enter non-dividing states, though the picture is more complicated. The original observation came from studies of the quiescent center in maize root tips, where researchers in the early 1970s found a mixed population of slowly cycling and non-cycling cells. The concept of a restriction point governing the choice between continued cycling and exit into G0 is well established in mammalian cells, but whether plant cells have an equivalent early checkpoint is still debated. Plants do have a late checkpoint analogous to yeast START, which governs cell size and growth, but the mammalian-style restriction point that gates G0 entry has not been definitively demonstrated in plants.3Oxford Academic. Cell cycle arrest in plants: what distinguishes quiescence, dormancy and differentiated G1?
This gap in our understanding is a reminder that G0 is not a universal, fully conserved state across all life. The molecular details differ between organisms, and even the boundaries of the concept are drawn differently depending on the system being studied. In mammals, the distinction between reversible quiescence and irreversible senescence or terminal differentiation is relatively clear. In plants, these categories blur in ways that researchers are still sorting out. What is shared across kingdoms is the fundamental principle: cells need a way to stop dividing without dying, and G0 is how they do it.